JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4251
State Street SPDR Dow Jones International Real Estate ETF
RWX
$239M
| $331K | ﹤0.01% |
8,521
+2,829
| +50% | +$110K |
2014 Q4
18 quarters
|
|
4252
First Internet Bancorp
INBK
$234M
| $329K | ﹤0.01% |
16,547
+5,759
| +53% | +$123K |
2017 Q3
7 quarters
|
|
4253
State Street Global Allocation ETF
GAL
$318M
| $328K | ﹤0.01% |
8,590
+3,917
| +84% | +$149K |
2015 Q1
17 quarters
|
|
4254
Hawkins
HWKN
$2.76B
| $326K | ﹤0.01% |
15,206
-572
| -4% | -$11K |
2016 Q2
12 quarters
|
|
|
TUES
4255
DELISTED
Tuesday Morning Corp
TUES
| $326K | ﹤0.01% |
+198,956
| New | +$362K |
2019 Q2
0 quarters
|
|
|
APLS
4256
DELISTED
Apellis Pharmaceuticals
APLS
| $325K | ﹤0.01% |
13,276
+4,465
| +51% | +$90.8K |
2017 Q4
6 quarters
|
|
|
BEDU
4257
DELISTED
Bright Scholar Education Holdings
BEDU
| $325K | ﹤0.01% |
8,137
+7,525
| +1,230% | +$319K |
2018 Q3
3 quarters
|
|
4258
Invesco Taxable Municipal Bond ETF
BAB
$834M
| $324K | ﹤0.01% |
10,301
| – | – |
2015 Q4
14 quarters
|
|
|
ITCI
4259
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $324K | ﹤0.01% |
+25,500
| New | +$327K |
2019 Q2
0 quarters
|
|
|
MCRN
4260
DELISTED
Milacron Holdings Corp.
MCRN
| $324K | ﹤0.01% |
24,785
-29,616
| -54% | -$396K |
2016 Q2
12 quarters
|
|
|
DSPG
4261
DELISTED
DSP Group Inc
DSPG
| $322K | ﹤0.01% |
22,498
+17,803
| +379% | +$257K |
2016 Q3
11 quarters
|
|
|
BAND
4262
Bandwidth Inc
BAND
$2.01B
| $321K | ﹤0.01% |
4,415
-64,749
| -94% | -$4.72M |
2018 Q2
4 quarters
|
|
4263
Magnolia Oil & Gas
MGY
$6.46B
| $320K | ﹤0.01% |
+27,760
| New | +$340K |
2019 Q2
0 quarters
|
|
4264
State Street SPDR S&P Telecom ETF
XTL
$554M
| $320K | ﹤0.01% |
4,762
-119
| -2% | -$8.35K |
2016 Q1
13 quarters
|
|
4265
CALL
DTE Energy
DTE
$26B
| $319K | ﹤0.01% |
+2,938
| New | +$315K |
2019 Q2
0 quarters
|
|
|
4266
PUT
DTE Energy
DTE
$26B
| $319K | ﹤0.01% |
+2,938
| New | +$315K |
2019 Q2
0 quarters
|
|
4267
Editas Medicine
EDIT
$428M
| $319K | ﹤0.01% |
13,632
+2,402
| +21% | +$57.3K |
2017 Q1
9 quarters
|
|
|
FONR
4268
DELISTED
Fonar
FONR
| $319K | ﹤0.01% |
15,344
-114,299
| -88% | -$2.34M |
2017 Q4
6 quarters
|
|
|
CTIC
4269
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $318K | ﹤0.01% |
373,867
-30,610
| -8% | -$28.3K |
2017 Q3
7 quarters
|
|
4270
Arvinas
ARVN
$488M
| $317K | ﹤0.01% |
13,358
+2,387
| +22% | +$50.2K |
2018 Q3
3 quarters
|
|
|
DO
4271
DELISTED
Diamond Offshore Drilling
DO
| $317K | ﹤0.01% |
37,190
-1,941,407
| -98% | -$18.6M |
2013 Q2
24 quarters
|
|
4272
CALL
Aurinia Pharmaceuticals
AUPH
$2.09B
| $316K | ﹤0.01% |
50,000
| – | – |
2019 Q1
1 quarter
|
|
|
4273
PUT
Aurinia Pharmaceuticals
AUPH
$2.09B
| $316K | ﹤0.01% |
50,000
| – | – |
2018 Q3
3 quarters
|
|
|
GAU
4274
Galiano Gold
GAU
$521M
| $316K | ﹤0.01% |
493,800
+191,100
| +63% | +$116K |
2017 Q2
8 quarters
|
|
4275
Invesco Ultra Short Duration ETF
GSY
$3.86B
| $315K | ﹤0.01% |
6,263
-10,636
| -63% | -$535K |
2018 Q2
4 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.